Viewing nowGlustap 30 mg (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201903743 · Approved 2019.06.05 · Insurance code 693903060
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes. It is primarily administered alone in conjunction with dietary and exercise therapy and can be used in combination with sulfonylureas, metformin, or insulin when other blood sugar lowering agents have shown limited effectiveness. Additionally, nutritional counseling, weight loss, and regular exercise alongside this medication significantly aid in blood sugar control and are essential for maintaining the effects of the therapy. Therefore, this medication is effectively used to improve blood sugar control in diabetes management.
This medicine is taken orally once daily, regardless of meals. For monotherapy, start with 15 mg once daily. If the effect is insufficient, the dose may be increased to up to 30 mg once daily. For combination therapy (with a sulfonylurea, metformin, or insulin), the initial dose is 15 mg once daily, and the maximum recommended dose should not exceed 30 mg once daily.
Use is not recommended in children under 18 years of age because there is no experience with its use in this population.
This medication is used for the treatment of type 2 diabetes and works to aid insulin action. However, it may exacerbate or cause heart failure in some patients, thus it should not be used in patients with existing heart disease or a history of heart failure. Patients should be closely monitored for signs of heart failure such as fluid retention leading to swelling, rapid weight gain, and shortness of breath while taking this medication, and should consult a doctor immediately if these symptoms occur. Furthermore, it should not be administered to patients with active bladder cancer or a history of bladder cancer, and if hematuria or urinary disturbances occur during treatment, the healthcare provider should be informed immediately. Patients with poor liver function or severe kidney dysfunction should also avoid this drug, and it is inappropriate for patients with diabetic ketoacidosis or type 1 diabetes. Women who are pregnant or may become pregnant should not take this medication, particularly premenopausal women due to its potential to stimulate ovulation, necessitating appropriate contraception. The risk of hypoglycemia may increase when this medication is used alongside other diabetes medications, so patients should be cautious of hypoglycemic symptoms and adjust dosages of other medications if necessary. Long-term use of this medication may lead to weight gain and edema, and the risk of fractures may also increase, so particularly female patients should pay attention to bone health. Regular monitoring of blood sugar and liver function tests during treatment is important, and any abnormal symptoms should be reported to a doctor immediately. Finally, the safety and efficacy of this medication have not been established in children, and caution should be exercised in the elderly.
Congestive heart failure, excessive and rapid weight change, dyspnea, edema, fluid retention, swelling, upper respiratory tract infection, headache, sinusitis, myalgia, pharyngitis, abdominal distension, weight gain, hypoglycemia, urinary tract infection, low back pain, dizziness, diarrhea, elevated serum creatine kinase, hypertension, heart failure, limb pain, chest pain, mortality due to cardiovascular predisposition, hospitalization due to worsening congestive heart failure, emergency room visit due to congestive heart failure, adverse cardiovascular events, dizziness, increased blood sugar, elevated ALT/AST, loss of appetite, constipation, upper abdominal pain, chest discomfort, fatigue, weakness, dyspepsia, nausea, dyspnea, itching, chest unease, tremors, chills, gastrointestinal disorders, abdominal pain, epigastric discomfort, numbness, muscle rigidity, head discomfort, increased liver enzymes, worsening liver disease, urticaria, eczema, arthralgia, knee abnormalities, arm weakness, proteinuria, increased serum creatinine, anxiety, insomnia, drowsiness, herpes simplex, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, abdominal pain, heart failure, adverse reactions related to edema, liver failure, macular edema, fracture
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that protects it from light and is airtight. Additionally, care should be taken to prevent moisture exposure, and the storage temperature should be maintained between 15 to 30 degrees Celsius, ideally around 25 degrees.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.